Cyclomics

Curated by Signal

Developer of liquid biopsybased diagnostic test for cancer detection

Overview

Developer of liquid biopsybased diagnostic test for cancer detection. It offers CyclomicsSeq TP53 a ctDNA detection assay based on long-read sequencing platforms, bioinformatics and AI platform.

Key facts

Founded: 2018
Headquarters: Utrecht, Netherlands
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Bambi Medical
Provider of wireless vital signs monitoring device for babies
Life Sciences TechnologyEindhoven, Netherlands
Optelec
Designs assistive technology products for low vision and visual impaired
Life Sciences TechnologyBarendrecht, Netherlands
Deena Bioinformatics
provides bioinformatics service
Life Sciences TechnologyNijmegen, Netherlands

About Cyclomics

What does Cyclomics do?

Developer of liquid biopsybased diagnostic test for cancer detection.

Where is Cyclomics headquartered?

Cyclomics is headquartered in Utrecht, Netherlands.

When was Cyclomics founded?

Cyclomics was founded in 2018.

Which sector is Cyclomics in?

Cyclomics operates in Life Sciences Technology.

Who are Cyclomics's competitors?

Companies similar to Cyclomics include Bambi Medical, Optelec, and Deena Bioinformatics.